Abstract
Alzheimer’s disease (AD) is characterized by the deposition of amyloid fibrillar aggregates in the intracellular and extracellular neuronal compartments. The factors which determine the topographic distribution of the lesions within the brain and the balance of amyloid deposition between extracellular and intracellular compartments are not yet understood. A certain proportion of AD patients have a family history of disease, some of which are clearly autosomal dominant and result in an earlier than usual age at onset and death (Masters et al 1981). Identification of a gene responsible for this form of familial AD (the FAD gene) would provide great insight into the mechanism of AD. The well-established association between Down’s syndrome (DS) and the premature development of AD also points to a gene-dosage effect arising from chromosome 21.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson, J; Wallace, W; Snyder, S; Haroutunian, V; Roberts, JL; Lieberburg, I. (1989) Cellular forms of the rat and human 8-amyloid precursor protein (BAPP) Brain Res; 478: 391–398.
Autilio-Gambetti, L; Morandi, A; Tabaton, M; Schaetzle, B; Kovacs, D; Perry, G; Greenberg, B and Gambetti, P. (1988) The amyloid precursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types. FERS Lett. 241: 94–98.
Bahmanyar S; Higgins GA; Goldgaber D; Lewis DA; Morrison JH; Wilson MC; Shankar SK and Gajdusek DC. (1987) Localization of amyloid ß protein messenger RNA in brains from Alzheimer’s disease patients. Science; 237: 77–80.
Beyreuther, K and Masters, CL. (1989) (in press) Nomenclature of amyloid A4 proteins and their precursors in Alzheimer’s disease and Down’s syndrome. Neurchiol Aging
Card, JP; Meade, RP; Davis, LG. (1988) Immunocytochemical localization of the precursor protein for 8-amyloid in the rat central nervous system. Neuron; 1: 835–846.
Cheng SV; Nadeau JH; Tanzi RE; Watkins PC; Jagadesh J; Taylor BA; Haines JL; Sacchi N and Gusella JF. (1988) Comparative mapping of DNA markers from the familial Alzheimer disease and Down syndrome regions of human chromosome 21 to mouse chromosomes 16 and 17. proc Natl Acad Sci USA; 85: 6032–6036.
Clark AW; Krekoski CA; Parhad IM; Liston D; Julien J-P; Hoar DI. (1989) Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex. Ann Neurol; 25: 331–339.
Cohen ML; Golde TE; Usiak MF; Younkin LH; .Younkin SG. (1988) Tn situ hybridization of nucleus basalis neurons shows increased ß-amyloid mRNA in Alzheimer disease. proc Nati Acad Sri 1LSA 85:1227–1231.
Cole G; Masliah E; Huynh TV; DeTeresa R; Terry RD; Okuda C and Saitoh T. (1989) An antiserum against amyloid 8-protein precursor detects a unique peptide in Alzheimer brain. Neuroaci Lett. 100: 340–346.
Davies L; Wolska B; Hilbich C; Multhaup G; Martins R; Simms G; Beyreuther K and Masters CL. (1988) A4 amyloid protein deposition and the diagnosis of Alzheimer’s disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology; 38: 1688–1693.
DeSauvage, F and Octave, J-N. (1989) A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. Soienre; 245: 651–653.
Dyrks, T; Weidemann, A; Multhaup, G; Salbaum, JM; Lemaire, H-G; Kang, J; Müller-Hill, B; Masters, CL and Beyreuther, K. (1988) Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer’s disease. FMRO J; 7: 949–957.
Gandy, S; Czenik, AJ and Greengard, P. (1988) Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Cat+/calmodulindependent protein kinase II. proc Natl Acad Sci USA* 85: 6218–6221.
Glenner, GG and Wong, CW. (1984) Alzheimer’s disease: initial report of the
purification and characterization of a novel cerebrovascular amyloid protein. Biochem Bioghys Res Comm• 120:885–890.
Goedert M. (1987) Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer’s disease. FMRO J. 6: 3627–3632.
Goldgaber, D; Lerman, MI; McBride, OW; Saffiotti, U and Gajdusek, DC. (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease. S ien 235: 877–880.
Higgins GA; Lewis DA; Bahmanyar S; Goldgaber D; Gajdusek DC; Young WG; Morrison JH; Wilson MC. (1988) Differential regulation of amyloid-ß-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc Nati Acad Sci USA; 85: 1297–1301.
Hyman BT; Van Hoesen GW; Beyreuther K and MastersCL. (1989) A4 amyloid protein immunoreactivity is present in Alzheimer’s disease neurofibrillary tangles. Neurasci Lett; 101: 352–355.
Ishii T; Kametani F; Haga S and Sato M. (1989) The immunohistochemical demonstration of subsequences of the precursor of the amyloid A4 protein in senile plaques in Alzheimer’s disease. Neurnpath Appi Neurnbiol; 15: 135–147.
Joachim CL; Mori H and Selkoe DJ. (1989) Amyloid ß-protein deposition in tissues other than brain in Alzheimer’s disease. Nature; 341: 226–230.
Johnson SA; Pasinetti GM; May PC; Ponte PA; Cordell B; Finch CE. (1988) Selective reduction of mRNA for the 8-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains. Exp Neurol; 102:264–268.
Kang, J; Lemaire, H-G; Unterbeck, A; Salbaum, JM; Masters, CL; Grzeschik, K-H; Multhaup, G; Beyreuther, K and Müller-Hill, B. (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature; 325: 733–736.
Kitaguchi, N; Takahashi, Y; Tokushima, Y; Shiojiri, S; Ito, H. (1988) Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature; 311: 530–532.
Koo EH; Sisodia SS; Archer DR; Martin LJ; Widemann A; Beyreuther K; Fischer P; Masters CL and Price DL. (submitted) Precursor of amyloid protein in Alzheimer’s disease undergoes fast anterograde axonal transport.
Lampert, PW. (1967) A comparative electron microscopic study of reactive degenerating, regenerating and dystrphic axons. J Neuropath Exp Neurol* 26:345368.
Lemaire HG; Salbaum JM; Multhaup G; Kang J; Bayney RM; Unterbeck A; Beyreuther K and Müller-Hill B. (1989) The pre A4 precursor protein of Alzheimer’s disease A4 amyloid is encoded by 16 exons. Nucl Acids Res 17: 517–522.
Masters, CL; Gajdusek, DC and Gibbs, CJ, Jr. (1981) The familial occurrence of Creutzfeldt-Jakob and Alzheimer’s disease. Brain; 104: 535–558.
Masters, CL; Multhaup, G; Simms, G; Pottgiesser, J; Martins, RN and Beyreuther, K. (1985b) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of
Alzheimer’s disease contain the same protein as the amyloid of plaque cores and blood vessels FMRO J; 4:2757–2763.
Masters, CL; Simms, G; Weinman, NA; Multhaup, G; McDonald, BL and Beyreuther, K. (1985a) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Prnc Nati Acad Sci USA; 82: 4245–4249.
Mita, S; Schon, EA; Herbert, J. (1989) Widespread expression of amyloid beta-protein precursor gene in rat brain. Am J Path - 134: 1253–1261.
Mobley WC; Neve RL; Prusiner SB and McKinley MP. (1988) Nerve growth factor increases mRNA levels for the prion protein and the ß-amyloid protein precursor in developing hamster brain. Proc Nati Acad Sci USA; 85: 9811–9815.
Neve RL; Finch EA; Dawes LR. (1988) Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron* 1: 669–677.
Octave J-N; DeSauvage F and Maloteaux J-M. (1989) Modification of neuronal cell adhesion affects the genetic expression of the A4 amyloid peptide precursor. Brain Res• 486: 369–371.
Oltersdorf T; Fritz LC; Schenk DB; Lieberburg I; Johnson-Wood KL; Beattie EC; Ward PJ; Blacher RW; Dovey HF; Sinha S. (1989) The secreted form of the Alzheimer’s amyloid precursor protein with the Kunitz domain is protease nexin II. Nature; 341: 144–147.
Palmert MR; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Nsiak MF; Younkin LH; Younkin SG. (1988) Amyloid protein precursor messenger RNAs: differential expression in Alzheimer’s disease. Br.ience; 241: 1080–1084.
Palmert MR; Podlisny MB; Witker DS; Oltersdorf T; Younkin LH; Selkoe, DJ and Younkin SG. (1989) The ß-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid Proc Natl Aced Sri USA; 86: 6338–6342.
Palmert MR; Podlisny MB; Witker DS; Oltersdorf T; Younkin LH; Selkoe DJ; Younkin SG. (1988) Antisera to an amino-terminal peptide detect the amyloid protein precursor of Alzheimer’s disease and recognise senile plaques. Binchem Fiophvs Res Comm. 156: 432–437.
Perry G; Lipphardt S; Mulvihill P; Kancherla M; Mijares M; Gambetti P; Sharma S; Maggiora L; Cornette J; Lobl T and Greenberg B. (1988) Amyloid precursor protein is in senile plaques of Alzheimer disease. Jzncet; 2: 746.
Pericak-Vance MA; Yamaoka LH; Haynes CS; Speer MC; Haines JL; Gaskell PC; Hung WY; Clark CM; Heyman AL; Trofatter JA; Eisenmenger JP; Gilbert JR; Lee JE; Alberts MJ; Dawson DV; Bartlett RJ; Earl NL; Siddique T; Vance JM; Conneally PM; Roses AD. (1988) Genetic linkage studies in Alzheimer’s disease families. Fxp Neurol• 102: 271–279.
Ponte, P; Gonzalez-DeWhitt, P; Schilling, J; Miller, J; Hsu, D; Greenberg, B; Davis, K; Wallace, W; Lieberburg, I; Fuller, F and Cordell, B. (1988) A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Naty re; 331: 525–527.
Prelli F; Castano, E; Glenner, GG and Frangone, B. (1988) Diferences between vascular and plaque core amyloid in Alzheimer’s disease. 1 Neurocheni; 51: 648–651.
Richards S-J; Waters JJ; Rogers DC; Martel FL; Sparkman DR; White CL; Beyreuther K; Masters CL and Dunnett SB. (in press) Hippocampal grafts derived from embryonic trisomy 16 mice exhibit amyloid (A4) and neurofibrillary pathology. Frog in Brain Rea.
Rosen DR; Martin-Morris L; Luo L and White K. (1989) A drosophila gene encoding a protein resembling the human ß-amyloid protein precursor. Proc Natl Acad Sri USA; 86: 2478–2482.
Rozemuller, JM; Eikelenboom, P; Stam, FC; Beyreuther, K and Masters, CL. (1989) A4 protein in Alzheimer’s disease: primary and secondary cellular events in extracellular amyloid deposition. J Neuropath Exp Neurol; 48: 674–691.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K and Masters CL. (1989) Amyloid A4 protein and its
precursor in Down’s syndrome and Alzheimer’s disease. N Eng J Made 320:1446–1452.
Saitoh T; Sundsmo M; Roch JM; Kumura N; Cole G; Schubert D; Oltersdorf T and Schenk DB. (1989) Secreted form of amyloid-3 protein precursor is involved in the growth regulation of fibroblasts. C11; 58: 615–622.
Salbaum JM; Lemaire H-G; Weidemann A; Masters CL and Beyreuther K. (1988) The promoter of Alzheimer’s disease amyloid A4 precursor gene. EMRO J; 7:28072813.
Schellenberg GD; Bird TD; Wijsman EM; Moore DK; Boehnke M; Bryant EM; Lampe TH; Nochlin D; Sumi SM; Deeb SS; Beyreuther K and Martin GM. (1988) Absence of linkage of chromosome 21q21 markers to familial Alzheimer’s disease. Scianca; 241: 1507–1510.
Schubert D; Cole G; Saitoh T and Oltersdort T. (1988b) Amyloid beta protein precursor is a mitogen. piocheur Bioph; 162: 1: 83–88.
Schubert D; LaCorbiere M; Saitoh T and Cole G. (1989a) Characterization of an amyloid ß precursor protein that binds heparin and contains tyrosine sulfate. Proc Natl Acad Sci USA; 86: 2066–2069.
Schubert W; Beer J; Weidemann A; Fischer P; Bunke D; Multhaup G; Salbaum JM; Masters CL and Beyreuther K.(submitted) Synaptic localization of the A4 protein precursor of the amyloid of Alzheimer’s disease.
Selkoe DJ; Bell DS; Podlisny MB; Price DL and Cork LC. (1987) Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer’s disease. Science; 235: 873–877.
Selkoe, DJ; Podlisny, M. Berman; Joachim CL; Vickers EA; Lee G; Fritz LC; Oltersdorf T. (1988) ß-amyloid precursor protein of Alzheimer disease occurs as 110- to 135- kilodalton membrane-associated proteins in neural and non-neural tissues. proc Natl Acad Sci USA; 85:7341–7345.
Shapira R; Austin GE; Mirra SS. (1988) Neuritic plaque amyloid in Alzheimer’s disease is highly racemized. T Nenrochem; 50: 69–74.
Shivers, BD; Hilbich, C; Multhaup, G; Salbaum, M; Beyreuther, K; Seeburg, PH. (1988) Alzheimer’s disease amyloidogenic glycoprotein: expression pattern in rat brain suggests role in cell contact FMBO J; 7: 1365–1370.
George-Hyslop PH; Tanzi RE; Polinsky RJ; Haines JL; Nee L; Watkins PC; Myers RH; Feldman RG; Pollen D; Drachman D; Growdon J; Bruni A; Foncin J-F; Salmon D; Frommelt P; Amaducci L; Sorbi S; Piacentini S; Stewart GD; Hobbs WJ; Conneally PM and Gusella JF. (1987) The genetic defect causing familial Alzheimer’s disease maps on chromosome 21 Science; 235: 885–890.
Takio K; Hasegawa M; Titani K and Ihara Y. (1989) Identification of ß protein precursor in newborn rat brain., Bionhem Biophys Res Comm; 160, 3: 1296–1301.
Tanaka S; Nakamura S; Ueda K; Kameyama M; Shiojiri S; Takahashi Y; Kitaguchi N; Ito H. (1988) Three types of amyloid protein precursor mRNA in human brain: Their differential expression in Alzheimer’s disease Biochem Biophys Res Commun; 157: 472–479.
Tanzi, RE; Gusella, JF; Watkins, PC; Bruns, GAP; St. George-Hyslop, P; van Keuren, ML; Patterson, D; Pagan, S; Kurnit, DM and Neve, RL. (1987) Amyloid ß protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science* 235: 880–884.
Tanzi, RE; McClatchey, AI; Lamperti, ED; Villa-Komarof, L; Gusella, JF; Neve, RL. (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer’s disease. Nature 311: 528–530.
Ostroff B; Majocha RE; Marotta CA. (1989) Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains. proc Natl Acad Sci tJSA; 86: 745–749.
Ueda K; Cole G; Sundsmo M; Katzman R; Saitoh T. (1989) Decreased adhesiveness of Alzheimer’s disease fibroblasts: Is amyloid 3-protein precursor involved? Lan Nenrol; 25: 246–251.
Van Broeckhoven C; Genthe AM; Vandenberghe A; Horsthemke B; Backhovens H; Raeymaekers P; Van Hul W; Wehnert A; Gheuens J; Cras P; Bruyland M; Martin JJ; Salbaum M; Multhaup G; Masters CL; Beyreuther K; Gurling HMD; Mullan MJ; Holland A; Barton A; Irving N; Williamson R; Richards SJ and Hardy JA. (1987) Failure of familial Alzheimer’s disease to segregate with the A4-amyloid gene in several European families Nature; 329: 153–155.
Van Nostrand WE; Cunningham DD. (1987) Purification of protease nexin II from human fibroblasts. T Biol Chem; 262: 8508–8514.
Van Nostrand WE; Wagner SL; Suzuki M; Choi BH; Farrow JS; Geddes JW; Coymass CW and Cunningham DD. (1989) Protease nexin-II, a poteut antichymotrypsin, shows identity to amyloid 3-protein precursor. Nature 341: 546–549.
Vitek MP; Rasool CG; de Sauvage F; Vitek SM; Bartus RT; Beer B; Ashton RA; Macq AF; Maloteaux J-M; Blume AJ and Octave J-N. (1988) Absence of mutation in the 3- amyloid cDNA cloned from the brains of three patients with sporadic Alzheimer’s disease. Molec Brain Res; 4:121–131.
Walker LC; Masters C; Beyreuther K and Price DL. (submitted) Amyloid in the brains of aged squirrel monkeys.
Weidemann A; König G; Bunke D; Fischer P; Salbaum, JM; Masters CL. and Beyreuther K. (1989) Identification, biogenesis and localization of precursors of Alzheimer’s disease A4 amyloid protein. Cell. 57: 115–126.
Whitson JS; Selkoe DJ; Cotman CW. (1989) Amyloid ß protein enhances the survival of hippocampal neurons in vitro. Science; 243: 148–1490.
Yankner BA; Dawes LR; Risher S; Villa-Komaroff L; Oster-Granite ML and Neve RL. (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease Science; 245: 417–420.
Zabel BU; Salbaum JM; Multhaup G; Masters CL; Bohl J and Beyreuther K. (1987) Sublocalization of the gene for the precursor of Alzheimer’s disease amyloid A4 protein on chromosome 21. Cytogenet Cell_Çenet; 46: 725–726.
Zain SB; Salim M; Chou WG; Sajdel-Sulkowska EM; Majoca RE and Marotta CA. (1988) Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer disease brain: Coding and noncoding regions of the fetal precursor mRNA are expressed in the cortex. Froc Natl Arad Sri USA; 85: 929–933.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Masters, C.L., Beyreuther, K. (1990). Amyloid ßA4 protein deposition in Alzheimer’s disease and Down’s Syndrome. In: Beyreuther, K., Schettler, G. (eds) Molecular Mechanisms of Aging. Veröffentlichungen aus der Geomedizinischen Forschungsstelle der Heidelberger Akademie der Wissenschaften, vol 1990 / 1990/2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84224-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-84224-5_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52732-9
Online ISBN: 978-3-642-84224-5
eBook Packages: Springer Book Archive